DarioHealth Corp. Earnings Per Share (Basic)
DarioHealth Corp. (DRIO) reported Earnings Per Share (Basic) of $0.85 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- DarioHealth Corp. earnings per share, basic for the quarter ending 2026-06-30 was $0.85, a 75.99% decline year-over-year.
- DarioHealth Corp. earnings per share, basic for the quarter ending 2026-03-31 was $1.25, a 56.45% decline year-over-year.
- DarioHealth Corp. earnings per share, basic for the quarter ending 2025-09-30 was $2.96, a 39.71% decline year-over-year.
- DarioHealth Corp. earnings per share, basic for the quarter ending 2025-06-30 was $3.54, a 4325.00% increase year-over-year.
- DarioHealth Corp. earnings per share, basic for fiscal 2025 was $10.12, a 17.52% decline from fiscal 2024.
- DarioHealth Corp. earnings per share, basic for fiscal 2024 was $12.27, a 535.75% increase from fiscal 2023.
- DarioHealth Corp. earnings per share, basic for fiscal 2023 was $1.93, a 24.02% decline from fiscal 2022.
- DarioHealth Corp. earnings per share, basic for fiscal 2022 was $2.54, a 37.59% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.85 10-Q · filed 2026-08-11 | $1.75 10-Q · filed 2026-08-11 | ||||||
| 2026-03-31 | $1.25 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | $10.12 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | $2.96 10-Q · filed 2025-11-13 | $9.05 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | $3.54 10-Q · filed 2026-08-11 | $0.18 10-Q · filed 2025-08-12 | $6.50 10-Q · filed 2026-08-11 | $0.33 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | $2.87 10-Q · filed 2026-05-13 | $0.14 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | $12.27 10-K · filed 2026-03-19 | $0.61 10-K · filed 2025-03-10 | ||||||
| 2024-09-30 | $4.91 10-Q · filed 2025-11-13 | $0.25 10-Q · filed 2024-11-07 | $10.38 10-Q · filed 2025-11-13 | $0.52 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | $0.08 10-Q · filed 2025-08-12 | $0.27 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | $0.20 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | $1.93 10-K · filed 2025-03-10 | |||||||
| 2023-09-30 | $0.49 10-Q · filed 2024-11-07 | $1.52 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | $0.58 10-Q · filed 2024-08-08 | $1.03 10-Q · filed 2024-08-08 | -$1.56 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$2.20 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2023-03-31 | $0.45 10-Q · filed 2024-05-15 | -$0.97 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.61 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$2.34 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.17 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.91 derived: net income ÷ weighted average shares · filed 2024-03-28 | $2.54 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $0.64 10-Q · filed 2023-11-02 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-11-02 | $2.02 10-Q · filed 2023-11-02 | $2.03 10-Q · filed 2022-11-14 | -$3.16 derived: net income ÷ weighted average shares · filed 2023-11-02 | |||
| 2022-06-30 | $0.74 10-Q · filed 2023-08-10 | $1.43 10-Q · filed 2023-08-10 | -$2.52 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$3.84 derived: net income ÷ weighted average shares · filed 2023-08-10 | ||||
| 2022-03-31 | $0.74 10-Q · filed 2023-05-11 | -$1.80 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$3.15 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$4.31 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||||
| 2021-12-31 | -$1.08 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$2.46 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$3.63 derived: net income ÷ weighted average shares · filed 2023-03-09 | $4.07 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $1.18 10-Q · filed 2022-11-14 | -$1.18 10-Q · filed 2021-11-15 | -$2.56 derived: net income ÷ weighted average shares · filed 2022-11-14 | $2.98 10-Q · filed 2022-11-14 | -$2.98 10-Q · filed 2021-11-15 | -$4.78 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||
| 2021-06-30 | $0.99 10-Q · filed 2022-08-15 | -$0.99 10-Q · filed 2021-08-16 | $1.85 10-Q · filed 2022-08-15 | -$1.85 10-Q · filed 2021-08-16 | -$3.34 derived: net income ÷ weighted average shares · filed 2022-08-15 | -$4.40 derived: net income ÷ weighted average shares · filed 2022-08-15 | ||
| 2021-03-31 | $0.92 10-Q · filed 2022-05-12 | -$2.16 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$3.20 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$4.31 derived: net income ÷ weighted average shares · filed 2022-05-12 | ||||
| 2020-12-31 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$2.06 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$3.17 derived: net income ÷ weighted average shares · filed 2022-03-22 | $4.01 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | -$0.71 10-Q · filed 2021-11-15 | -$2.14 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$2.95 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$0.68 10-Q · filed 2021-08-16 | -$2.33 10-Q · filed 2021-08-16 | ||||||
| 2015-09-30 | -$0.05 10-Q · filed 2015-11-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$0.19 10-Q · filed 2015-11-13 | |||||
| 2015-06-30 | -$0.07 10-Q · filed 2015-08-12 | -$0.15 10-Q · filed 2015-08-12 | ||||||
| 2014-09-30 | -$0.66 10-Q · filed 2015-11-13 | -$0.59 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$2.03 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | -$0.14 10-Q · filed 2015-08-12 | -$0.28 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$0.14 10-Q · filed 2014-05-14 | |||||||
| 2013-09-30 | -$0.85 10-Q · filed 2014-11-14 | -$3.95 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | -$0.29 10-Q · filed 2014-08-14 | -$0.63 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | -$0.35 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |